Oculis: eye drops with Dexamethasone/gamma-CD complex Phase 3 study concluded soon
Oculis’s most advanced product candidate, OCS-01, is currently in Phase 3 development and aims to be the first eye drop
A forum for researchers, students and applicants in the field of cyclodextrin technology
Oculis’s most advanced product candidate, OCS-01, is currently in Phase 3 development and aims to be the first eye drop
The adsorption of drugs and their carriers onto double-stranded DNA is potentially significant for their transport and release within cells,
In recent decades, the biomedical and pharmaceutical potential of cyclodextrins has expanded remarkably. Their well‑established host–guest complexation ability continues to
Obesity is a multifaceted disease that significantly increases the risk of various chronic conditions. GLP-1R (co)-agonists first emerged as therapeutics
The present Special Issue in Polymers welcomes contributions in the form of original research articles, preclinical investigations, or review articles
Catheter locks are used to prevent infection and clotting in indwelling catheters, but most current locks are simple liquids. These
The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the
This study investigates the PEG‑β‑CD polymer, a water‑soluble polyethylene glycol–β‑cyclodextrin cross‑linked carrier, as a potential alternative to conventional oestradiol formulations
Previous studies have demonstrated that the solubility and biocompatibility of poorly water-soluble anti-cancer agents can be improved by complexation with
The aim of the present study was to complex the potent steroidal hormones progesterone (PRO) and 17β-estradiol (BES) with heptakis(2,6-di-O-methyl)-β-cyclodextrin